PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for September 03, 2013


Shutterstock photo

PDL BioPharma, Inc. ( PDLI ) will begin trading ex-dividend on September 03, 2013. A cash dividend payment of $0.15 per share is scheduled to be paid on September 12, 2013. Shareholders who purchased PDLI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 12th quarter that PDLI has paid the same dividend. At the current stock price of $7.86, the dividend yield is 7.63%.

The previous trading day's last sale of PDLI was $7.86, representing a -7.26% decrease from the 52 week high of $8.48 and a 20.92% increase over the 52 week low of $6.50.

PDLI is a part of the Health Care sector, which includes companies such as Gilead Sciences, Inc. ( GILD ) and Amgen Inc. ( AMGN ). PDLI's current earnings per share, an indicator of a company's profitability, is $1.64. Zacks Investment Research reports PDLI's forecasted earnings growth in 2013 as 18.54%, compared to an industry average of 5.7%.

For more information on the declaration, record and payment dates, visit the PDLI Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to PDLI through an Exchange Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:

  • WisdomTree Trust SmallCap Dividend Fund ( DES )
  • WisdomTree SmallCap Earnings Fund ( EES ).

The top-performing ETF of this group is EES with an increase of 14.27% over the last 100 days. DES has the highest percent weighting of PDLI at 0.88%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , Stocks
Referenced Symbols: AMGN , DES , EES , GILD , PDLI

More from NASDAQ.com News


NASDAQ.com News

NASDAQ.com News

Market News
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com